002107SZSE

Legal Opinion on the 2025 Annual Shareholders' Meeting of Wohuah Pharmaceutical

WoHua Pharmaceuticals Co., Ltd.··5 pages

✨ AI Summary

This legal opinion confirms the compliance of Wohuah Pharmaceutical's 2025 Annual Shareholders' Meeting with relevant laws and regulations. The meeting was convened on February 9, 2026, with 51.6171% of voting shares represented. Key resolutions included the approval of the 2025 Board Work Report and Financial Settlement Report, both receiving over 99% approval. The voting procedures were deemed legal and valid.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Legal Opinion on the 2025 Annual Shareholders' Meeting of Wohuah Pharmaceutical

To: Wohuah Pharmaceutical Technology Co., Ltd.

Beijing Xinghe Law Firm (hereinafter referred to as "this firm") has been entrusted by Wohuah Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "your company") to issue this legal opinion regarding the convening of your company's 2025 Annual Shareholders' Meeting (hereinafter referred to as "this meeting"). This opinion is based on the relevant provisions of the Company Law of the People's Republic of China (hereinafter referred to as "Company Law"), the Securities Law of the People's Republic of China (hereinafter referred to as "Securities Law"), the Rules for Shareholders' Meetings of Listed Companies (hereinafter referred to as "Meeting Rules"), and the Articles of Association of Wohuah Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Articles of Association").

To issue this legal opinion, this firm appointed lawyers to attend this meeting. The lawyers witnessed the entire process of the meeting and verified the documents and facts related to the convening of this meeting. The lawyers agree to disclose this legal opinion as part of your company's announcement documents for this shareholders' meeting, along with other documents that should be announced to the public, and shall bear legal responsibility for the legal opinions expressed by this firm's lawyers.

According to the relevant provisions of the Company Law, Meeting Rules, and Articles of Association, and in accordance with the publicly available standards, ethical norms, and the spirit of diligence and responsibility in the legal profession, the legal opinions regarding this meeting are as follows:

1. On the Convening and Holding Procedures of This Meeting

On January 19, 2026, your company held the seventh meeting of the eighth board of directors and decided to convene this meeting on February 9, 2026. On January 20, 2026, your company published the "Notice of Wohuah Pharmaceutical Technology Co., Ltd. on Convening the 2025 Annual Shareholders' Meeting" in the China Securities Journal, Securities Times, and on the Giant Tide Information Network (http://cninfo.com.cn), detailing the time, location, method of convening, agenda items, attendees, and registration methods for this meeting.

At 14:00 on February 9, 2026, this meeting was held as scheduled in the company conference room, presided over by Vice Chairman Ms. Zhao Caixia, with lawyers from this firm present to witness the process of the meeting.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.